Insufficient scRNA-seq data for expression of P2RY2 at single-cell level.
Insufficient scRNA-seq data for expression of P2RY2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1021.02 | 652 / 653 | 91% | 8.32 | 549 / 605 |
lung | 94% | 378.57 | 546 / 578 | 89% | 4.76 | 1025 / 1155 |
bladder | 62% | 215.38 | 13 / 21 | 89% | 5.71 | 448 / 504 |
breast | 57% | 178.83 | 262 / 459 | 86% | 6.08 | 960 / 1118 |
esophagus | 42% | 1056.13 | 611 / 1445 | 91% | 9.23 | 167 / 183 |
intestine | 44% | 206.91 | 427 / 966 | 85% | 3.21 | 449 / 527 |
liver | 79% | 200.25 | 179 / 226 | 49% | 1.03 | 199 / 406 |
adrenal gland | 94% | 373.60 | 242 / 258 | 19% | 0.76 | 43 / 230 |
muscle | 100% | 2921.53 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.18 | 1 / 1 |
spleen | 99% | 414.98 | 238 / 241 | 0% | 0 | 0 / 0 |
stomach | 21% | 38.44 | 74 / 359 | 74% | 2.63 | 213 / 286 |
ovary | 4% | 6.87 | 7 / 180 | 91% | 4.46 | 390 / 430 |
tonsil | 0% | 0 | 0 / 0 | 93% | 9.61 | 42 / 45 |
uterus | 12% | 46.78 | 21 / 170 | 80% | 6.40 | 368 / 459 |
heart | 92% | 493.94 | 792 / 861 | 0% | 0 | 0 / 0 |
pancreas | 5% | 7.90 | 15 / 328 | 82% | 3.01 | 146 / 178 |
prostate | 66% | 205.87 | 161 / 245 | 16% | 0.27 | 78 / 502 |
skin | 70% | 365.31 | 1263 / 1809 | 11% | 0.29 | 50 / 472 |
blood vessel | 65% | 167.62 | 867 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 63% | 318.26 | 587 / 929 | 0% | 0 | 0 / 0 |
kidney | 43% | 95.03 | 38 / 89 | 13% | 0.29 | 121 / 901 |
brain | 13% | 26.86 | 344 / 2642 | 6% | 0.10 | 39 / 705 |
adipose | 11% | 20.07 | 134 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.08 | 1 / 29 |
eye | 0% | 0 | 0 / 0 | 1% | 0.04 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0035589 | Biological process | G protein-coupled purinergic nucleotide receptor signaling pathway |
GO_0006873 | Biological process | intracellular monoatomic ion homeostasis |
GO_0097746 | Biological process | blood vessel diameter maintenance |
GO_0070257 | Biological process | positive regulation of mucus secretion |
GO_0071318 | Biological process | cellular response to ATP |
GO_0005886 | Cellular component | plasma membrane |
GO_0045030 | Molecular function | G protein-coupled UTP receptor activity |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0031686 | Molecular function | A1 adenosine receptor binding |
GO_0045028 | Molecular function | G protein-coupled purinergic nucleotide receptor activity |
Gene name | P2RY2 |
Protein name | P2Y purinoceptor 2 (P2Y2) (ATP receptor) (P2U purinoceptor 1) (P2U1) (P2U receptor 1) (Purinergic receptor) P2Y purinoceptor 2 |
Synonyms | P2RU1 |
Description | FUNCTION: Receptor for ATP and UTP coupled to G-proteins that activate a phosphatidylinositol-calcium second messenger system. The affinity range is UTP = ATP > ATP-gamma-S >> 2-methylthio-ATP = ADP. |
Accessions | ENST00000393596.2 ENST00000311131.6 P41231 ENST00000393597.7 C6G7W2 C6G7W1 |